Jun Bei Liu talks us through some rare stock picks and talks the potential US-China trade deal, we walk through the charts and talk WBC, MQG and BHP, and ask a bullion expert: why is Gen Z suddenly buying gold?
Peter Switzer is joined by Marcus Bogdan from Blackmore Capital, Raymond Chan from Morgans and Paul Rickard from the Switzer Report.
Peter Switzer talks with Wellnex Life (WNX) CEO, George Karafotias.
Fibre comes in two parts. Soluble fibre and insoluble fibre. In today's episode, Dr Ross tells us why fibre is so important.
Peter Switzer is joined by Jun Bei Liu of Tribeca Investment Partners, Michelle May from buyers agent and Anne Flaherty from REA group.
Peter Switzer shares his thoughts on the major current affairs impacting financial markets and the economy.
There have always been rumours on whether mobile phones are really linked with an increased risk for brain cancer. In this week's episode, Dr Ross looks at certain studies to assess this claim.
Peter Switzer is joined by Michael Wayne of Medallion Financial, ST Wong of Prime Value, and CEO of Rate Money, Ryan Gair.
Peter Switzer is joined by Michael Gable of Fairmont Equities, and Marcus Bogdan of Blackmore Capital.
Currently, the only form of male contraception is a condom and a vasectomy. However, through certain studies and research conducted with mice, we may soon see a contraception pill for males with no hormonal effects.
3 reasons why Dr Phil better be careful about raising interest rates & could stocks slide tomorrow?
Peter Switzer is joined by Jun Bei Liu of Tribeca Investment Partners, Anthony Doyle from Firetrail Investments and Paul Rickard is joined by Angus Moore from Proptrack.
Dr Ross explains whether immunotherapy could be the new approach that could lead to an effective treatment for various types of cancer.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox